Phase II trial of a combination of weekly docetaxel and four-weekly carboplatin in the first-line treatment of advanced non-small cell lung cancer (NSCLC)
Author
Mandel, Nil
Yildiz, Ozcan
Yanmaz, Teoman
Serdengecti, Suheyla
Ozguroglu, Mustafa
Evrensel, Turkkan
Er, Ozlem
Turna, Hande
Metadata
Show full item recordCollections
- Bildiri [64839]